Nisshin Seifun Group Inc. (FRA:NFR)
10.60
+0.10 (0.95%)
At close: Jan 30, 2026
Nisshin Seifun Group Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 85,515 | 93,968 | 109,470 | 82,971 | 69,607 | 61,282 |
Short-Term Investments | 29,427 | 2,150 | - | - | 1,103 | 452 |
Cash & Short-Term Investments | 114,942 | 96,118 | 109,470 | 82,971 | 70,710 | 61,734 |
Cash Growth | 0.57% | -12.20% | 31.94% | 17.34% | 14.54% | 7.86% |
Receivables | 118,714 | 109,035 | 113,995 | 107,246 | 100,052 | 84,972 |
Inventory | 122,853 | 120,641 | 124,878 | 128,786 | 96,596 | 81,606 |
Other Current Assets | 13,394 | 12,934 | 16,729 | 11,066 | 13,169 | 10,362 |
Total Current Assets | 369,903 | 338,728 | 365,072 | 330,069 | 280,527 | 238,674 |
Property, Plant & Equipment | 257,073 | 251,000 | 235,815 | 217,494 | 219,379 | 215,428 |
Long-Term Investments | 179,533 | 167,138 | 191,711 | 130,669 | 147,481 | 152,943 |
Goodwill | 4,594 | 5,018 | 6,212 | 7,496 | 42,385 | 45,551 |
Other Intangible Assets | 17,453 | 15,957 | 15,351 | 16,181 | 26,367 | 27,825 |
Long-Term Deferred Tax Assets | - | 11,871 | 12,539 | 11,964 | 6,933 | 6,992 |
Other Long-Term Assets | 21,459 | 1 | 2 | 1 | 1 | 2 |
Total Assets | 850,015 | 789,713 | 826,702 | 713,874 | 723,073 | 687,415 |
Accounts Payable | 84,591 | 64,872 | 76,198 | 74,565 | 63,655 | 47,946 |
Accrued Expenses | 22,879 | 26,295 | 27,036 | 23,247 | 24,727 | 21,869 |
Short-Term Debt | 13,250 | 13,141 | 15,101 | 14,356 | 6,789 | 5,547 |
Current Income Taxes Payable | 6,665 | 7,502 | 7,890 | 8,941 | 5,784 | 5,022 |
Other Current Liabilities | 43,849 | 35,503 | 37,346 | 29,153 | 28,203 | 28,356 |
Total Current Liabilities | 171,234 | 147,313 | 163,571 | 150,262 | 129,158 | 108,740 |
Long-Term Debt | 31,411 | 31,244 | 32,014 | 33,378 | 33,785 | 34,729 |
Long-Term Leases | 43,886 | 40,148 | 39,929 | 37,311 | 38,939 | 36,673 |
Pension & Post-Retirement Benefits | 21,791 | 21,935 | 23,532 | 23,422 | 22,845 | 22,533 |
Long-Term Deferred Tax Liabilities | 44,268 | 37,689 | 42,671 | 22,097 | 28,360 | 30,562 |
Other Long-Term Liabilities | 8,903 | 8,815 | 8,606 | 8,907 | 9,345 | 9,405 |
Total Liabilities | 321,493 | 287,144 | 310,323 | 275,377 | 262,432 | 242,642 |
Common Stock | 17,117 | 17,117 | 17,117 | 17,117 | 17,117 | 17,117 |
Additional Paid-In Capital | 12,560 | 12,560 | 12,752 | 12,728 | 12,622 | 12,627 |
Retained Earnings | 346,906 | 341,375 | 344,428 | 325,181 | 347,165 | 341,241 |
Treasury Stock | -8,653 | -1,470 | -10,914 | -10,989 | -10,960 | -10,997 |
Comprehensive Income & Other | 141,213 | 115,423 | 136,918 | 79,839 | 83,324 | 73,216 |
Total Common Equity | 509,143 | 485,005 | 500,301 | 423,876 | 449,268 | 433,204 |
Minority Interest | 19,379 | 17,564 | 16,078 | 14,621 | 11,373 | 11,569 |
Shareholders' Equity | 528,522 | 502,569 | 516,379 | 438,497 | 460,641 | 444,773 |
Total Liabilities & Equity | 850,015 | 789,713 | 826,702 | 713,874 | 723,073 | 687,415 |
Total Debt | 88,547 | 84,533 | 87,044 | 85,045 | 79,513 | 76,949 |
Net Cash (Debt) | 26,395 | 11,585 | 22,426 | -2,074 | -8,803 | -15,215 |
Net Cash Growth | -19.58% | -48.34% | - | - | - | - |
Net Cash Per Share | 91.20 | 39.19 | 75.41 | -6.97 | -29.60 | -51.17 |
Filing Date Shares Outstanding | 285.83 | 289.72 | 297.51 | 297.38 | 297.4 | 297.37 |
Total Common Shares Outstanding | 285.83 | 289.72 | 297.51 | 297.38 | 297.4 | 297.37 |
Working Capital | 198,669 | 191,415 | 201,501 | 179,807 | 151,369 | 129,934 |
Book Value Per Share | 1781.31 | 1674.04 | 1681.64 | 1425.38 | 1510.67 | 1456.76 |
Tangible Book Value | 487,096 | 464,030 | 478,738 | 400,199 | 380,516 | 359,828 |
Tangible Book Value Per Share | 1704.17 | 1601.64 | 1609.16 | 1345.76 | 1279.49 | 1210.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.